American Journal of Clinical Nutrition, Vol 66, 1020S-1031S, Copyright © 1997 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Are fish oils beneficial in the prevention and treatment of coronary artery disease?

SL Connor and WE Connor
Department of Medicine, Oregon Health Sciences University, Portland 97201-3098, USA. connors@ohsu.edu

The n-3 fatty acids of fish and fish oil have great potential for the prevention and treatment of patients with coronary artery disease. Unlike many of the pharmaceutical agents used in patients with coronary artery disease that have just a single mechanism of action, the eicosapentaenoic and docosahexaenoic acids of fish oil have multifaceted actions. One of their most important effects is the prevention of arrhythmias, with documentation derived from experiments in cultured myocytes, experiments in animals, epidemiologic correlations, and clinical trials. Especially important is the ability of these n-3 fatty acids to inhibit ventricular fibrillation and consequent cardiac arrest. Eicosapentaenoic acid has several antithrombotic actions, particularly in inhibiting the synthesis of thromboxane A2, the prostaglandin that causes platelet aggregation and vasoconstriction. Fish oil retards the growth of the atherosclerotic plaque by inhibiting both cellular growth factors and the migration of monocytes. The n-3 fatty acids promote the synthesis of the beneficial nitric oxide in the endothelium. Experiments in humans indicate a profound hypolipidemic effect of fish oil, especially lowering of plasma triacylglycerol. Both very-low-density lipoprotein production and apolipoprotein B synthesis are inhibited by fish oil. Finally, fish oil has a mild blood pressure-lowering effect in both normal and mildly hypertensive individuals. These composite effects suggest a prominent therapeutic role for fish oil in the prevention and treatment of coronary artery disease.

This article has been cited by other articles:

				N. Shimojo, S. Jesmin, S. Zaedi, M. Soma, T. Kobayashi, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi EPA Effect on NOS Gene Expression and on NO Level in Endothelin-1-Induced Hypertrophied Cardiomyocytes. Experimental Biology and Medicine, June 1, 2006; 231(6): 913 - 918. [Abstract] [Full Text] [PDF]

				D. Lopez, X. Orta, K. Casos, M. P. Saiz, P. Puig-Parellada, M. Farriol, and M. T. Mitjavila Upregulation of endothelial nitric oxide synthase in rat aorta after ingestion of fish oil-rich diet Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H567 - H572. [Abstract] [Full Text] [PDF]

				K. W. Lee and G. Y. H. Lip Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392. [Abstract] [Full Text] [PDF]

				A. Andersson, C. Nalsen, S. Tengblad, and B. Vessby Fatty acid composition of skeletal muscle reflects dietary fat composition in humans Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1222 - 1229. [Abstract] [Full Text] [PDF]

				M. Anderson and K. L. Fritsche (n-3) Fatty Acids and Infectious Disease Resistance J. Nutr., December 1, 2002; 132(12): 3566 - 3576. [Abstract] [Full Text] [PDF]

				D. W. Nilsen, G. Albrektsen, K. Landmark, S. Moen, T. Aarsland, and L. Woie Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol Am. J. Clinical Nutrition, July 1, 2001; 74(1): 50 - 56. [Abstract] [Full Text] [PDF]

				R. U Almario, V. Vonghavaravat, R. Wong, and S. E Kasim-Karakas Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia Am. J. Clinical Nutrition, July 1, 2001; 74(1): 72 - 79. [Abstract] [Full Text] [PDF]

				D. Lopez, C. Caballero, J. Sanchez, P. Puig-Parellada, and M. T. Mitjavila Free radical production in aortic rings from rats fed a fish oil-rich diet Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2929 - H2935. [Abstract] [Full Text] [PDF]

				D. Bhatnagar, M.I. Mackness, and P.N. Durrington Treatment of mixed hyperlipidaemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D53 - D58. [Abstract] [PDF]

				K. D Stark, E. J Park, V. A Maines, and B. J Holub Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial Am. J. Clinical Nutrition, August 1, 2000; 72(2): 389 - 394. [Abstract] [Full Text] [PDF]

				W. E Connor Harbingers of coronary heart disease: dietary saturated fatty acids and cholesterol. Is chocolate benign because of its stearic acid content? Am. J. Clinical Nutrition, December 1, 1999; 70(6): 951 - 952. [Full Text] [PDF]

				J. H. Christensen, M. S. Christensen, J. Dyerberg, and E. B. Schmidt Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids Am. J. Clinical Nutrition, September 1, 1999; 70(3): 331 - 337. [Abstract] [Full Text] [PDF]

				S. S. D. Nair, J. Leitch, J. Falconer, and M. L Garg Cardiac (n-3) Non-Esterified Fatty Acids Are Selectively Increased in Fish Oil-Fed Pigs following Myocardial Ischemia J. Nutr., August 1, 1999; 129(8): 1518 - 1523. [Abstract] [Full Text]